259 related articles for article (PubMed ID: 28738039)
1. Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers.
Jackson-Rose J; Del Monte J; Groman A; Dial LS; Atwell L; Graham J; O'Neil Semler R; O'Sullivan M; Truini-Pittman L; Cunningham TA; Roman-Fischetti L; Costantinou E; Rimkus C; Banavage AJ; Dietz B; Colussi CJ; Catania K; Wasko M; Schreffler KA; West C; Siefert ML; Rice RD
Clin J Oncol Nurs; 2017 Aug; 21(4):438-445. PubMed ID: 28738039
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy Extravasation: Incidence of and Factors Associated With Events in a Community Cancer Center.
Ehmke N
Clin J Oncol Nurs; 2021 Dec; 25(6):680-686. PubMed ID: 34800094
[TBL] [Abstract][Full Text] [Related]
3. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
Sauerland C; Engelking C; Wickham R; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
[TBL] [Abstract][Full Text] [Related]
4. Risk management of extravasation of cytostatic drugs at the Adult Chemotherapy Outpatient Clinic of a university hospital.
Adami NP; de Gutiérrez MG; da Fonseca SM; de Almeida EP
J Clin Nurs; 2005 Aug; 14(7):876-82. PubMed ID: 16000102
[TBL] [Abstract][Full Text] [Related]
5. A flow sheet for follow-up after chemotherapy extravasation.
Davis ME; DeSantis D; Klemm K
Oncol Nurs Forum; 1995 Jul; 22(6):979-83. PubMed ID: 7567616
[TBL] [Abstract][Full Text] [Related]
6. European Oncology Nursing Society extravasation guidelines.
Wengström Y; Margulies A;
Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
[TBL] [Abstract][Full Text] [Related]
7. Preventing and managing vesicant chemotherapy extravasations.
Schulmeister L
J Support Oncol; 2010; 8(5):212-5. PubMed ID: 21086879
[TBL] [Abstract][Full Text] [Related]
8. Managing vesicant extravasations.
Schulmeister L
Oncologist; 2008 Mar; 13(3):284-8. PubMed ID: 18378538
[TBL] [Abstract][Full Text] [Related]
9. Vesicant extravasation: myths and realities.
Boyle DM; Engelking C
Oncol Nurs Forum; 1995; 22(1):57-67. PubMed ID: 7708525
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy extravasation from implanted ports.
Schulmeister L; Camp-Sorrell D
Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
[TBL] [Abstract][Full Text] [Related]
11. Vesicant extravasation part II: Evidence-based management and continuing controversies.
Wickham R; Engelking C; Sauerland C; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1143-50. PubMed ID: 17149397
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic.
Sakaida E; Sekine I; Iwasawa S; Kurimoto R; Uehara T; Ooka Y; Akanuma N; Tada Y; Imai C; Oku T; Takiguchi Y
Jpn J Clin Oncol; 2014 Feb; 44(2):168-71. PubMed ID: 24302758
[TBL] [Abstract][Full Text] [Related]
13. Eliminating extravasation events: a multidisciplinary approach.
Coyle CE; Griffie J; Czaplewski LM
J Infus Nurs; 2014; 37(3):157-64. PubMed ID: 24694509
[TBL] [Abstract][Full Text] [Related]
14. Eliminating Extravasation Events: A Multidisciplinary Approach.
Coyle CE; Griffie J; Czaplewski LM
J Infus Nurs; 2015; 38 Suppl 6():S43-50. PubMed ID: 26536412
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy drug extravasation in totally implantable venous access port systems: how effective is early surgical lavage?
Azaïs H; Bresson L; Bassil A; Katdare N; Merlot B; Houpeau JL; El Bedoui S; Meurant JP; Tresch E; Narducci F
J Vasc Access; 2015; 16(1):31-7. PubMed ID: 25362986
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of the patient receiving infusional cancer chemotherapy: nursing role in recognition and management of catheter-related complications. The Cancer Center of Boston.
Moore C; Strong D; Childress J; Fougere B; Gotthardt S
J Infus Chemother; 1996; 6(4):171-80. PubMed ID: 9229312
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological management of anticancer agent extravasation: A single institutional guideline.
Kimmel J; Fleming P; Cuellar S; Anderson J; Haaf CM
J Oncol Pharm Pract; 2018 Mar; 24(2):129-138. PubMed ID: 29284352
[TBL] [Abstract][Full Text] [Related]
18. [Extravasation of cytostatic agents: a serious complication of oncological treatment].
Alfaro-Rubio A; Sanmartín O; Requena C; Llombart B; Botella-Estrada R; Nagore E; Serra-Guillén C; Hueso L; Guillén C
Actas Dermosifiliogr; 2006 Apr; 97(3):169-76. PubMed ID: 16796963
[TBL] [Abstract][Full Text] [Related]
19. Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapy.
Haslik W; Hacker S; Felberbauer FX; Thallinger C; Bartsch R; Kornauth C; Deutschmann C; Mader RM
Eur J Surg Oncol; 2015 Mar; 41(3):378-85. PubMed ID: 25515823
[TBL] [Abstract][Full Text] [Related]
20. Taxanes: vesicants, irritants, or just irritating?
Barbee MS; Owonikoko TK; Harvey RD
Ther Adv Med Oncol; 2014 Jan; 6(1):16-20. PubMed ID: 24381657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
